Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB26FWQWG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,998
Award facts
- Contract value 100% obligated
- $5,997.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Cosentyx (secukinumab) 300 mg pens in 2 mL formulations, with a ceiling value of $5,997.79. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of November 6, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor specializing in comprehensive pharmaceutical and medical supply procurement for military and veteran healthcare systems. The company's selection for this delivery order reflects its demonstrated capability to competitively meet federal procurement requirements. The underlying IDC serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support Defense Health Agency programs and other government healthcare systems worldwide. This delivery order exemplifies the company's role as a primary vendor within the DLA's medical supply chain operations.
Quick answers
Who was awarded contract SPE2DB26FWQWG?
SPE2DB26FWQWG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 5, 2025.
How much is contract SPE2DB26FWQWG worth?
The government has obligated $5,998 on SPE2DB26FWQWG.
Is contract SPE2DB26FWQWG an order under another contract?
Yes. SPE2DB26FWQWG is a delivery order under SPE2DB25D3007, an indefinite delivery contract.
Was contract SPE2DB26FWQWG competed?
The extent of competition for SPE2DB26FWQWG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award